ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

32,691Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 780

$1.56M Total Retail Price of All Prescriptions

Rank: 11 out of 780

1,256 Patients Receiving at Least One Drug in Part D
48%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 1,256 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

41% of this provider’s 1,256 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 16,334 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 2,894 1,295 S3 1 1
OMEPRAZOLE 1,478 786 2 3
SIMVASTATIN 1,393 769 3 2
GABAPENTIN 840 389 4 13
METFORMIN HCL 836 392 5 8
ZOLPIDEM TARTRATE 784 351 6 17
LEVOTHYROXINE SODIUM 737 381 7 5
AMLODIPINE BESYLATE 711 400 8 4
FUROSEMIDE 679 367 9 7
LISINOPRIL 656 358 10 6
MELOXICAM 573 248 11 16
POTASSIUM CHLORIDE 539 259 12 11
CITALOPRAM HBR 497 238 13 23
ATORVASTATIN CALCIUM 485 282 14 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 372 197 15 26
TRAMADOL HCL 369 198 16 15
LYRICA 347 131 17 52
ESCITALOPRAM OXALATE 320 128 18 61
NEXIUM 312 141 19 22
METOPROLOL SUCCINATE 306 193 20 20
TIZANIDINE HCL 296 70 21 82
CYCLOBENZAPRINE HCL 287 117 R 22 42
WARFARIN SODIUM 285 189 23 24
CLOPIDOGREL 280 195 24 34
TAMSULOSIN HCL 262 164 25 36
CARVEDILOL 247 132 26 14
CARBIDOPA-LEVODOPA 244 133 27 124
CRESTOR 244 80 27 32
PANTOPRAZOLE SODIUM 242 139 29 25
METOPROLOL TARTRATE 239 103 30 19
ALLOPURINOL 238 170 31 29
PROMETHAZINE HCL 237 51 R 32 66
ATENOLOL 235 125 33 21
SPIRIVA 223 92 34 72
LOSARTAN POTASSIUM 215 110 35 18
ZETIA 212 116 36 94
PROAIR HFA 199 69 37 62
LOSARTAN-HYDROCHLOROTHIAZIDE 199 109 37 33
AMITRIPTYLINE HCL 192 106 R 39 48
ADVAIR DISKUS 190 90 40 68
FLUTICASONE PROPIONATE 189 96 41 41
FENOFIBRATE 188 100 42 63
SERTRALINE HCL 187 75 43 27
VENTOLIN HFA 178 62 44 91
ENDOCET 178 67 S2 44 129
DIOVAN HCT 177 106 46 75
HYDROCHLOROTHIAZIDE 174 123 47 10
CARISOPRODOL 174 0 R 47 67
PLAVIX 168 108 49 45
PAROXETINE HCL 167 86 50 69
RANITIDINE HCL 166 94 51 39
PRAMIPEXOLE DIHYDROCHLORIDE 165 74 52 156
PRAVASTATIN SODIUM 164 46 53 9
BYSTOLIC 156 118 54 118
CYMBALTA 155 69 55 51
TRAZODONE HCL 149 59 56 35
ALENDRONATE SODIUM 149 116 56 44
LANTUS SOLOSTAR 148 60 58 121
AMOXICILLIN 147 63 59 99
ROPINIROLE HCL 144 53 60 87
ESTRADIOL 135 41 R 61 122
POLYETHYLENE GLYCOL 3350 133 75 62 79
TOPIRAMATE 130 24 63 145
AZITHROMYCIN 120 51 64 38
VESICARE 119 44 65 186
METFORMIN HCL ER 118 50 66 43
PEN NEEDLE 118 49 66 136
CLONIDINE HCL 118 50 66 28
CHLORTHALIDONE 114 77 69 142
TORSEMIDE 113 77 70 114
AMLODIPINE BESYLATE-BENAZEPRIL 112 62 71 50
ISOSORBIDE MONONITRATE ER 109 56 72 60
MECLIZINE HCL 109 60 72 83
DIGOXIN 109 89 72 56
VERAPAMIL ER 107 46 75 78
METHOCARBAMOL 105 30 R 76 84
COMBIVENT 102 68 77 189
LOVASTATIN 100 82 78 47
KLOR-CON M20 97 53 79 57
LEXAPRO 97 56 79 219
FLUOXETINE HCL 96 43 81 65
DALIRESP 96 30 81 386
ETODOLAC 92 35 83 174
TRIAMTERENE-HCTZ 88 47 84 37
GLIMEPIRIDE 85 47 85 30
KLOR-CON 10 82 40 86 90
TRICOR 82 42 86 152
PREMARIN 78 47 R 88 110
NAMENDA 77 72 89 46
SINGULAIR 77 16 89 73
RISPERIDONE 77 32 89 98
DONEPEZIL HCL 73 73 92 31
DIPHENOXYLATE-ATROPINE 73 26 92 250
SYNTHROID 73 61 92 77
VENLAFAXINE HCL 69 20 95 226
RAMIPRIL 69 40 95 70
SYMBICORT 66 16 97 181
DIOVAN 64 30 98 55
NAPROXEN 63 17 99 100
MOEXIPRIL-HYDROCHLOROTHIAZIDE 61 49 100 336
AVODART 60 46 101 255
PROPRANOLOL HCL 59 45 102 133
JANUVIA 59 51 102 85
COLCRYS 59 31 102 131
OXYBUTYNIN CHLORIDE ER 59 41 102 169
METHYLPREDNISOLONE 58 23 106 92
FINASTERIDE 58 43 106 150
CIPROFLOXACIN HCL 56 37 108 49
HYDRALAZINE HCL 56 47 108 54
INSULIN SYRINGE 56 25 108 80
VENLAFAXINE HCL ER 55 13 111 117
SUMATRIPTAN SUCCINATE 55 16 111 301
BUPROPION HCL SR 55 30 111 193
DOXYCYCLINE HYCLATE 54 34 114 103
ONGLYZA 54 26 114 232
HUMALOG 53 18 116 192
LOVAZA 51 0 117 183
OXYCODONE HCL-ACETAMINOPHEN 50 24 S2 118 146
ISOSORBIDE MONONITRATE 50 21 118 293
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.